30 Nov 2011
Author(s): 
The RTS,S Clinical Trials Partnership

Please contact us at mvi_info [at] path.org for the French version of this article.

An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.